BrightSpring Health Services, Inc. (BTSG)
As of Sep 18, 2026, BrightSpring Health Services, Inc. (BTSG) scores 5.3/10 on AlphaStocks' five-model composite, #83 of 168 Health Care stocks. At $57, BTSG trades 114% above its model fair value of $27.
Health Care / Health Care Services
S&P MidCap 400$56.62
Below average on several measures. Research carefully.
Consider Buy
Score based on 4 of 5 models — moderate confidence
Data as of Sep 18, 2026
Is BrightSpring Health Services, Inc. a Good Investment in 2026?
BrightSpring Health Services, Inc. (BTSG) scores 5.3 out of 10 on AlphaStocks' composite model, earning a Consider Buy rating. The Piotroski model rates BrightSpring Health Services, Inc. as Strong (7/9). However, the Greenblatt Magic Formula model rates it Caution — Earnings yield 1.6% · ROC 24%. BrightSpring Health Services, Inc. currently trades 114% above its estimated fair value of $27. BrightSpring Health Services, Inc. ranks #83 out of 168 stocks in the Health Care sector.
This summary is algorithmically generated and is not financial advice.
Key Metrics
Estimated Fair Value
Trading above estimated fair value. P/e of 65x implies high growth expectations. rapid eps growth (716%) partially justifies the premium.
Model-based estimate, not a price target.
5-Model Analysis
Each model evaluates this stock from a different angle. Combined, they form the composite score above.
Piotroski
Strong
7/9
Buffett
Caution
Business quality & competitive moat
Graham
Caution
Significantly above fair value
Lynch
Limited Data
Growth rate vs price (PEG)
Greenblatt
Caution
Earnings yield 1.6% · ROC 24%
Frequently Asked Questions
Is BrightSpring Health Services, Inc. (BTSG) a good investment?
What is BrightSpring Health Services, Inc.'s Piotroski F-Score?
Is BTSG overvalued or undervalued?
How does BTSG compare to other Health Care stocks?
What do investment models say about BTSG?
Similar Stocks
Compare BTSG with
Scores are algorithm-generated research tools, not investment recommendations. Past performance does not guarantee future results. Always do your own due diligence. Full disclaimer